Status:

COMPLETED

The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.

Lead Sponsor:

Shanghai Chest Hospital

Conditions:

Atrial Fibrillation, Persistent

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This is an open label, multi-center, randomized parallel control clinical trial, to demonstrate the role of driver mechanism in maintenance substrate of persistent atrial fibrillation, and evaluate th...

Detailed Description

This is an open label, multi-center, randomized parallel control clinical trial. Patients with persistent atrial fibrillation are 1:1 randomized into the experimental group (driver ablation+ circumfer...

Eligibility Criteria

Inclusion

  • Aged 18 to 80 years old;
  • Persistent AF;
  • nonresponse or intolerance to ≥1 antiarrhythmic drug. -

Exclusion

  • With uncontrolled congestive heart failure;
  • Having significant valvular disease and/or prosthetic heart valve(s);
  • With myocardial infarction or stroke within 6 months of screening;
  • With Significant congenital heart disease;
  • Ejection fraction was \<40% measured by echocardiography;
  • Allergic to contrast media;
  • Contraindication to anticoagulation medications;
  • Severe pulmonary disease e.g. restrictive pulmonary disease, chronic obstructive disease (COPD);
  • Left atrial (LA) thrombus measured by pre-procedure transesophageal echocardiography;
  • Having any contraindication to right or left sided heart catheterization;
  • Previous atrial fibrillation ablation;
  • Presence of an implanted cardioverter-defibrillator;
  • Any cardiac surgery within the past 2 months;
  • Poor general health;
  • Life expectancy less than 6 months.

Key Trial Info

Start Date :

August 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2022

Estimated Enrollment :

1298 Patients enrolled

Trial Details

Trial ID

NCT04489004

Start Date

August 1 2020

End Date

December 1 2022

Last Update

February 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Chest Hospital

Shanghai, China

The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation. | DecenTrialz